Protocol No.: COG-ACNS1833

Title
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727, IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
Principal Investigator
Paul, Stephan
Phase
III
Age Group
Both
Applicable Disease Site
Brain Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Jan Rapp
Clinical Trials Manager
Phone: +1 304-293-1229
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217
April Shay, MSN, PNP-BC
Nurse Practitioner
Phone: +1 304-293-1217
Christy Glass, MSN
APRN
Phone: +1 304-598-4835
Denise Casino
Clinical Trials Manager
Phone: +1 304-293-0735

View on ClinicalTrials.gov